ATE486599T1 - Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür - Google Patents
Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafürInfo
- Publication number
- ATE486599T1 ATE486599T1 AT05751188T AT05751188T ATE486599T1 AT E486599 T1 ATE486599 T1 AT E486599T1 AT 05751188 T AT05751188 T AT 05751188T AT 05751188 T AT05751188 T AT 05751188T AT E486599 T1 ATE486599 T1 AT E486599T1
- Authority
- AT
- Austria
- Prior art keywords
- composition containing
- pharmaceutical composition
- amlodipinesilate
- production method
- lisinopril dihydrate
- Prior art date
Links
- 229960002394 lisinopril Drugs 0.000 title abstract 2
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
- 229950004221 besilate Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401170A HUP0401170A2 (en) | 2004-06-10 | 2004-06-10 | Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for |
| PCT/HU2005/000064 WO2005120502A1 (en) | 2004-06-10 | 2005-06-09 | New pharmaceutical composition and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486599T1 true ATE486599T1 (de) | 2010-11-15 |
Family
ID=89985289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05751188T ATE486599T1 (de) | 2004-06-10 | 2005-06-09 | Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1765342B9 (enExample) |
| AT (1) | ATE486599T1 (enExample) |
| CY (1) | CY1111484T1 (enExample) |
| DE (1) | DE602005024554D1 (enExample) |
| DK (1) | DK1765342T3 (enExample) |
| EA (1) | EA010288B1 (enExample) |
| ES (1) | ES2354618T3 (enExample) |
| HR (1) | HRP20110034T1 (enExample) |
| HU (2) | HUP0401170A2 (enExample) |
| ME (1) | ME01935B (enExample) |
| PL (1) | PL1765342T4 (enExample) |
| PT (1) | PT1765342E (enExample) |
| RS (1) | RS51677B (enExample) |
| SI (1) | SI1765342T1 (enExample) |
| WO (1) | WO2005120502A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2790817A1 (en) * | 2010-02-24 | 2011-09-01 | Sanofi-Aventis Deutschland Gmbh | Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| RU2483728C1 (ru) * | 2011-09-29 | 2013-06-10 | Общество с ограниченной ответственностью "Озон" | Комбинированное гипотензивное средство и способ его получения |
| PL227900B1 (pl) * | 2012-11-15 | 2018-01-31 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję |
| CN105194647A (zh) * | 2014-06-30 | 2015-12-30 | 南京瑞尔医药有限公司 | 一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法 |
| CN106333948A (zh) * | 2016-08-23 | 2017-01-18 | 成都尚药科技有限公司 | 含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法 |
| JP7179758B2 (ja) * | 2017-04-25 | 2022-11-29 | 大塚製薬株式会社 | 摂取可能なイベントマーカを有するリシノプリル組成物 |
| GB2595203A (en) | 2020-03-03 | 2021-11-24 | Alkaloid Ad Skopje | Formulation |
| CN119730841A (zh) * | 2022-09-07 | 2025-03-28 | 拉塞·凯那司特 | Api含量提高的氨氯地平的立即释放口服药物形式 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11500140A (ja) | 1995-03-16 | 1999-01-06 | ファイザー・インコーポレーテッド | アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物 |
| HUP0202416A3 (en) | 2002-07-24 | 2006-01-30 | Richter Gedeon Vegyeszet | Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders |
-
2004
- 2004-06-10 HU HU0401170A patent/HUP0401170A2/hu unknown
-
2005
- 2005-06-09 AT AT05751188T patent/ATE486599T1/de active
- 2005-06-09 ME MEP-2010-496A patent/ME01935B/me unknown
- 2005-06-09 PT PT05751188T patent/PT1765342E/pt unknown
- 2005-06-09 PL PL05751188.3T patent/PL1765342T4/pl unknown
- 2005-06-09 RS RS20100496A patent/RS51677B/sr unknown
- 2005-06-09 EA EA200602187A patent/EA010288B1/ru unknown
- 2005-06-09 HU HUE05751188A patent/HUE009867T4/hu unknown
- 2005-06-09 DE DE602005024554T patent/DE602005024554D1/de not_active Expired - Lifetime
- 2005-06-09 WO PCT/HU2005/000064 patent/WO2005120502A1/en not_active Ceased
- 2005-06-09 SI SI200531194T patent/SI1765342T1/sl unknown
- 2005-06-09 HR HR20110034T patent/HRP20110034T1/hr unknown
- 2005-06-09 EP EP05751188A patent/EP1765342B9/en not_active Expired - Lifetime
- 2005-06-09 ES ES05751188T patent/ES2354618T3/es not_active Expired - Lifetime
- 2005-06-09 DK DK05751188.3T patent/DK1765342T3/da active
-
2010
- 2010-12-30 CY CY20101101203T patent/CY1111484T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005120502A1 (en) | 2005-12-22 |
| PT1765342E (pt) | 2010-12-20 |
| PL1765342T4 (pl) | 2022-11-07 |
| DE602005024554D1 (de) | 2010-12-16 |
| EA010288B1 (ru) | 2008-08-29 |
| CY1111484T1 (el) | 2015-08-05 |
| PL1765342T3 (pl) | 2011-04-29 |
| EP1765342A1 (en) | 2007-03-28 |
| ES2354618T3 (es) | 2011-03-16 |
| SI1765342T1 (sl) | 2011-02-28 |
| HUE009867T2 (enExample) | 2011-05-30 |
| EP1765342B9 (en) | 2011-02-23 |
| ME01935B (me) | 2011-10-31 |
| DK1765342T3 (da) | 2011-01-24 |
| HRP20110034T1 (hr) | 2011-02-28 |
| HUE009867T4 (hu) | 2022-01-28 |
| HUP0401170A2 (en) | 2006-09-28 |
| EA200602187A1 (ru) | 2007-04-27 |
| EP1765342B1 (en) | 2010-11-03 |
| RS51677B (sr) | 2011-10-31 |
| HU0401170D0 (en) | 2004-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| HUP0400992A3 (en) | Carboxylic acid substituted oxazole derivatives, process for their preparation and their use as ppar-alpha and-gamma activators for the manufacture of pharmaceutical compositions in the treatment of diabetes | |
| ATE411280T1 (de) | Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| BR0312000A (pt) | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos | |
| MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
| BRPI0408439A (pt) | composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético | |
| EP1784388B8 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| CY1111484T1 (el) | Φαρμακευτικη συνθεση που περιεχει αμλοδιπινη βεσυλικη και λισινοπριλη διυδρικη και μεθοδος παρασκευης αυτης | |
| DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
| MXPA02011389A (es) | Forma de administracion farmaceutica para peptidos, procedimiento para su preparacion y aplicacion. | |
| ATE480244T1 (de) | Neue, hyaluronsäure oder hyaluronsaure derivate und collagenase enthaltende pharmazeutische zusammensetzungen zur topischen behandlung von wunden, verbrennungen und geschwüren | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| ATE459342T1 (de) | Wirkstoff und trimagnesiumdicitrat als trockenmittel enthaltende stabilisierte feste arzneimittelformen und verfahren zu ihrer herstellung | |
| ATE518533T1 (de) | Pharmazeutische zusammensetzung, die einen spezifischen aminopeptidase-a inhibitor enthält, insbesondere ec33, zur senkung des blutdrucks | |
| PT1218401E (pt) | 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao | |
| TR200003451T2 (tr) | Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları | |
| WO2023150790A3 (en) | Novel and highly selective sars-cov-2 mpro inhibitors | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| CA2534259A1 (en) | Glycyrrhizin high-concentration preparation | |
| WO2004093827A3 (en) | Phenolic acid salts of gabapentin in solid dosage forms and methods of use | |
| PT1432407E (pt) | Composicoes de lisinopril que possuem dcpd de particulas grandes | |
| DE602006003848D1 (de) | Formulierung zur verzögerten Freisetzung von Valproinsäure und deren Derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1765342 Country of ref document: EP |